On September 25, Gelonhui reported that Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) disclosed that on September 24, 2024, Guoshenghaitong private enterprise high-quality development fund reduced its holdings of the company's unrestricted circulating shares by 9,900 shares through centralized competitive bidding on the Shanghai Stock Exchange. The reduction accounted for 0.002416% of the company's total share capital. After this equity change, Guoshenghaitong private enterprise high-quality development fund holds 20,490,100 shares of the company, accounting for 4.999997% of the total share capital, no longer a shareholder holding more than 5% of the company.